Start Your Search
P51 - Small Cell Lung Cancer/NET - Surgery (ID 238)
- Event: WCLC 2020
- Type: Posters
- Track: Small Cell Lung Cancer/NET
- Presentations: 1
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
P51.01 - Total Lung Preservation: An Important Tool in Treatment of Bronchial Carcinoids (Neuroendocrine Tumours) (ID 3512)
00:00 - 00:00 | Presenting Author(s): Prriya Eshpuniyani
Neuroendocrine accounting for less than 1% of all lung tumors warrant radical surgery as their gold standard treatment option particularly for pulmonary carcinoids. Over last three decades sleeve resections has proved to be popular and oncologically safe option. Our objective was to evaluate whether total lung preservation is as oncologically safe as sleeve lobectomies in selected cases.Methods
We retrospectively analyzed all patients of bronchopulmonary carcinoid tumours who underwent total lung preservation with sleeve resection and compared with the sleeve lobectomies at our institute over last 15 years. We evaluated and compared the perioperative events, follow up, quality of life and long term survival of these patients.Results
Of the 86 patients operated for bronchopulmonary carcinoids, 40 underwent bronchial Sleeve resection. 16 of these sleeve resections were achieved with total lung preservation rest requiring sleeve lobectomies. Median age for total lung preservation patients is 40 years wherein for sleeve lobectomy was 43 years.
There was no postoperative complication or perioperative mortality in any patient. Median duration of drain and stay were comparable. Average follow up was 3.6 years for total lung preservation and 3.4 years for sleeve resections. One patient of sleeve lobectomy with G2 disease died to relapse of the disease after 2 years. All patients had a good quality of life in the long follow up with no respiratory compromise.Conclusion
In selective patients of main bronchial carcinoids, total lung preservation with sleeve resection/ bronchoplasty gives a oncologically similar outcome, quality of life and long term survival as compared to sleeve lobectemies for carcinoid.